BRIEF published on 04/28/2025 at 14:35, 1 year ago Convocation à l'Assemblée Générale Ordinaire d'Électricité de Strasbourg Électricité De Strasbourg Durabilité Rémunération Des Dirigeants Dividendes 2024 Assemblée Générale Ordinaire 2025
BRIEF published on 04/28/2025 at 14:35, 1 year ago Call for the Ordinary General Meeting of Electricité de Strasbourg Sustainability Executive Compensation Dividends 2024 Strasbourg Electricity Ordinary General Meeting 2025
BRIEF published on 04/28/2025 at 14:35, 1 year ago Prof. Dr. Vignali Joins Secarna Pharmaceuticals' Scientific Board Scientific Advisory Board Immuno-oncology Secarna Pharmaceuticals SECN-15 Prof. Dr. Vignali
BRIEF published on 04/28/2025 at 14:35, 1 year ago Le professeur Vignali rejoint le conseil scientifique de Secarna Pharmaceuticals Immuno-oncologie Secarna Pharmaceuticals Conseil Consultatif Scientifique SECN-15 Prof. Dr. Vignali
BRIEF published on 04/28/2025 at 14:25, 1 year ago Audius SE Proposes Dividend of 20 Cents per Share Annual General Meeting Financial Year 2024 Dividend Proposal IT And Telecommunications Frankfurt And Munich Stock Exchanges
BRIEF published on 04/28/2025 at 14:25, 1 year ago Audius SE propose un dividende de 20 cents par action Assemblée Générale Annuelle Proposition De Dividende Exercice Financier 2024 Informatique Et Télécommunications Bourses De Francfort Et De Munich
BRIEF published on 04/28/2025 at 14:20, 1 year ago Jaguar Health to Reveal Initial Findings on Crofelemer for MVID and SBS-IF Crofelemer Microvillus Inclusion Disease Short Bowel Syndrome Investor Webcast Jaguar Health
BRIEF published on 04/28/2025 at 14:20, 1 year ago Jaguar Health dévoilera les premiers résultats de Crofelemer pour le MVID et le SBS-IF Crofelemer Jaguar Health Syndrome De L'intestin Court Webcast Pour Les Investisseurs Maladie D'inclusion Microvillositaire
BRIEF published on 04/28/2025 at 14:09, 1 year ago Mainz Biomed's First Quarter 2025 Update and FDA Approval Progress Strategic Partnerships FDA Approval Colorectal Cancer Stock Market Compliance MRNA Biomarkers
BRIEF published on 04/28/2025 at 14:09, 1 year ago Mise à jour du premier trimestre 2025 de Mainz Biomed et progrès de l'approbation de la FDA Partenariats Stratégiques Cancer Colorectal Approbation De La FDA Biomarqueurs D'ARNm Conformité Du Marché Boursier
Published on 04/29/2026 at 19:37, 42 minutes ago Alphinat Announces a Net Loss of $(166,109) for Quarter Ended February 28, 2026
Published on 04/29/2026 at 15:15, 5 hours 4 minutes ago Reeflex Solutions Inc. Announces Filing of Q2 2026 Financial Results
Published on 04/29/2026 at 15:10, 5 hours 9 minutes ago Karbon-X Introduces Corporate Emissions Calculator as Pressure to Quantify Carbon Exposure Accelerates
Published on 04/29/2026 at 14:31, 5 hours 48 minutes ago Worksport (NASDAQ:WKSP) Secures Tri-State Distribution, Books Initial Orders, Projected to be 7-Figure + Annual Account
Published on 04/29/2026 at 20:00, 19 minutes ago Onlineprinters confirms FY 2025 results and provides outlook for 2026
Published on 04/29/2026 at 20:00, 19 minutes ago lePERMISLIBRE met fin au contrat de liquidité confié à TP ICAP (Europe)
Published on 04/29/2026 at 19:45, 34 minutes ago VAZIVA SA: FORTE PROGRESSION DES RESULTATS ANNUELS 2025 - PERSPECTIVES 2026
Published on 04/29/2026 at 19:27, 52 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/29/2026 at 18:15, 2 hours 4 minutes ago GUILLEMOT CORPORATION | MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL INCLUANT LE RAPPORT FINANCIER ANNUEL 2025
Published on 04/29/2026 at 18:15, 2 hours 4 minutes ago GUILLEMOT CORPORATION | AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT INCLUDING THE 2025 ANNUAL FINANCIAL REPORT
Published on 04/29/2026 at 18:10, 2 hours 9 minutes ago Amemdment of the resolution n8 submitted to the AGM of 30 April 2026
